dIRF4-2 is a first-in-class proteolysis-targeting chimera of IRF4, by linking (S)-H1 to E3 ligase ligands of cereblon. dIRF4-2 achieves highly selective IRF4 knockdown (DC50 ~2.2–2.3 µM) without degrading off-target neosubstrates such as IKZF1/3 or GSPT1, and demonstrates strong cytotoxic effects across all multiple myeloma cell lines tested in vitro.

Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months.
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.